- |||||||||| Trial completion, Trial completion date: Reverse Transcriptase Inhibitors in AGS (clinicaltrials.gov) - Mar 5, 2019
P2, N=11, Completed, Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Jun 2018
- |||||||||| Enrollment closed, Enrollment change: Reverse Transcriptase Inhibitors in AGS (clinicaltrials.gov) - Dec 21, 2017
P2, N=11, Active, not recruiting, Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Jun 2018 Recruiting --> Active, not recruiting | N=24 --> 11
- |||||||||| Enrollment open, Trial primary completion date: Reverse Transcriptase Inhibitors in AGS (clinicaltrials.gov) - Oct 7, 2015
P2, N=24, Recruiting, Active, not recruiting --> Completed Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2017 --> Mar 2018
- |||||||||| Trial initiation date, Trial primary completion date: Reverse Transcriptase Inhibitors in AGS (clinicaltrials.gov) - Apr 15, 2015
P2, N=24, Not yet recruiting, Trial primary completion date: Jun 2015 --> Oct 2015 Initiation date: Mar 2015 --> Sep 2015 | Trial primary completion date: Aug 2017 --> Dec 2017
|